El Paso Energy Corp. Lab. If you are looking for an ideal introduction into mid-cap success, I recommend to investors a stock that I recently recommended to my MPT Review subscribers, Forest Labs . The company s most important products in the U.S. are branded ethical drug specialties. Forest s products treat hypertension, angina, respiratory distress syndrome in premature infants, and depression.
Treatment of depression is a huge market.
In the United States and Western and Eastern Europe, Forest's ethical specialty products are marketed directly by the company s Forest Pharmaceuticals, Forest Therapeutics and Forest Specialty Sales salesforces. The company s generic products are marketed directly by its Inwood Laboratories, Inc. subsidiary and through independent distributors. And you can believe that institutions are keeping an eye on Forest Labs. There is no doubt that the safest neighborhood on Wall Street will continue to be wherever new money is headed. Right now, if you are an aggressive investor, I recommend that at least 60 percent of your portfolio be devoted to selected mid-cap growth stocks.